ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 675,62
-0,26%
Dow Jones
39 375,87
0,17%
DAX
18 475,45
0,12%
Brent Oil
86,775
0,00%
Bitcoin
57 205,29
-1,88%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Aziyo Biologics Inc (AZYO)

  7. Aziyo Biologics Inc (AZYO) Actualités

AZYO

Aziyo Biologics (AZYO)

Aziyo Biologics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AZYO
DateHeureSourceTitreSymboleSociété
22/04/202422h33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:AZYOAziyo Biologics Inc
22/04/202422h30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:AZYOAziyo Biologics Inc
01/04/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AZYOAziyo Biologics Inc
08/09/202314h30GlobeNewswire Inc.Elutia to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AZYOAziyo Biologics Inc
06/09/202322h05GlobeNewswire Inc.Aziyo Biologics Rebrands as Elutia to Reflect Strategic Focus on Drug Eluting BiomatricesNASDAQ:AZYOAziyo Biologics Inc
30/08/202314h30GlobeNewswire Inc.Aziyo Biologics Announces Publication of a CanGaroo® Case Study Demonstrating Bioenvelope Benefits for Reoperative ProceduresNASDAQ:AZYOAziyo Biologics Inc
14/08/202323h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AZYOAziyo Biologics Inc
14/08/202322h05GlobeNewswire Inc.Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix CompanyNASDAQ:AZYOAziyo Biologics Inc
31/07/202322h05GlobeNewswire Inc.Aziyo Biologics to Report Second Quarter 2023 Financial Results on Monday, August 14, 2023NASDAQ:AZYOAziyo Biologics Inc
17/07/202322h05PR Newswire (US)SWK Holdings Highlights Recent Achievements and Provides Portfolio UpdateNASDAQ:AZYOAziyo Biologics Inc
13/07/202322h30GlobeNewswire Inc.Aziyo Biologics Announces Voluntary Recall of Viable Bone Matrix ProductsNASDAQ:AZYOAziyo Biologics Inc
23/06/202317h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AZYOAziyo Biologics Inc
09/06/202322h32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AZYOAziyo Biologics Inc
19/05/202314h15GlobeNewswire Inc.Aziyo Biologics Presents Positive Clinical Data on CanGaroo® Biologic EnvelopeNASDAQ:AZYOAziyo Biologics Inc
12/05/202323h16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AZYOAziyo Biologics Inc
10/05/202322h05GlobeNewswire Inc.Aziyo Biologics Reports Highest Sales and Gross Profit in Company HistoryNASDAQ:AZYOAziyo Biologics Inc
03/05/202322h05GlobeNewswire Inc.Aziyo Biologics to Report First Quarter 2023 Financial Results on Wednesday, May 10, 2023NASDAQ:AZYOAziyo Biologics Inc
20/04/202322h30GlobeNewswire Inc.Aziyo Biologics and LeMaitre Vascular Partner for the Distribution of Aziyo’s Cardiovascular PortfolioNASDAQ:AZYOAziyo Biologics Inc
07/04/202312h01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AZYOAziyo Biologics Inc
23/03/202322h10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AZYOAziyo Biologics Inc
22/03/202321h01GlobeNewswire Inc.Aziyo Biologics Reports Record Full Year 2022 RevenuesNASDAQ:AZYOAziyo Biologics Inc
22/03/202313h30GlobeNewswire Inc.Aziyo Biologics and Sientra Announce SimpliDerm® Partnership to Improve Women’s Access to Biologics for Soft Tissue ReconstructionNASDAQ:AZYOAziyo Biologics Inc
20/03/202313h00GlobeNewswire Inc.Aziyo Biologics Provides Update on FDA Submission for CanGaroo® RM Antibacterial EnvelopeNASDAQ:AZYOAziyo Biologics Inc
15/03/202321h05GlobeNewswire Inc.Aziyo Biologics to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 22, 2023NASDAQ:AZYOAziyo Biologics Inc
27/02/202314h15GlobeNewswire Inc.Aziyo Biologics to Present at the Cowen 43rd Annual Health Care ConferenceNASDAQ:AZYOAziyo Biologics Inc
14/02/202300h56Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AZYOAziyo Biologics Inc
31/01/202314h00PR Newswire (US)SWK Holdings Provides Portfolio Update Highlighting Recent AchievementsNASDAQ:AZYOAziyo Biologics Inc
09/01/202314h15GlobeNewswire Inc.Aziyo Biologics Announces Record Annual Net Sales in Preliminary (Unaudited) Fourth Quarter and Full Year 2022 Topline ResultsNASDAQ:AZYOAziyo Biologics Inc
15/12/202214h00GlobeNewswire Inc.Aziyo Biologics Announces Funding of Additional $4 Million Term Loan with SWK Holdings CorporationNASDAQ:AZYOAziyo Biologics Inc
07/12/202222h32Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:AZYOAziyo Biologics Inc
 Showing the most relevant articles for your search:NASDAQ:AZYO

Dernières Valeurs Consultées

BOV
ALPAG920
ALPAG920 Ex:9,2
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés